爱伦医疗
(920050)
| 流通市值：5.41亿 | | | 总市值：20.23亿 |
| 流通股本：1810.27万 | | | 总股本：6767.93万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,040,215,976.13 | 641,650,456.84 | 294,537,632.66 | 988,730,443.01 |
| 营业总成本 | 909,769,573.15 | 568,435,337.08 | 270,217,152.17 | 884,757,579.38 |
| 其他经营收益 | | | | |
| 营业利润 | 119,854,999.92 | 61,229,390 | 23,525,156.57 | 102,806,046.21 |
| 利润总额 | 118,215,823.17 | 59,535,353.09 | 23,559,392.81 | 101,982,397.89 |
| 净利润 | 107,936,114.75 | 57,296,353.56 | 21,379,798.94 | 93,491,526.55 |
| 每股收益 | | | | |
| 其他综合收益 | -30,938,879.26 | -22,224,125.59 | -14,249,850.65 | 10,119,796.38 |
| 综合收益总额 | 76,997,235.49 | 35,072,227.97 | 7,129,948.29 | 103,611,322.93 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 613,668,638.85 | 599,952,456.79 | 661,915,454.59 | 412,913,680.13 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,060,379,472.72 | 1,010,468,234.17 | 979,796,502.49 | 950,277,595.52 |
| 资产总计 | 1,674,048,111.57 | 1,610,420,690.96 | 1,641,711,957.08 | 1,363,191,275.65 |
| 流动负债: | | | | |
| 流动负债合计 | 554,096,730.15 | 521,745,469.36 | 492,818,724.13 | 484,854,618.42 |
| 非流动负债: | | | | |
| 非流动负债合计 | 17,032,077.99 | 15,545,343.55 | 35,715,843.7 | 33,764,219 |
| 负债合计 | 571,128,808.14 | 537,290,812.91 | 528,534,567.83 | 518,618,837.42 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,089,354,249.13 | 1,048,231,351.87 | 1,085,779,586.73 | 835,280,218.21 |
| 股东权益合计 | 1,102,919,303.43 | 1,073,129,878.05 | 1,113,177,389.25 | 844,572,438.23 |
| 负债和股东权益合计 | 1,674,048,111.57 | 1,610,420,690.96 | 1,641,711,957.08 | 1,363,191,275.65 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,071,005,470.96 | 697,264,110.8 | 367,053,562.09 | 1,088,035,095.15 |
| 经营活动现金流出小计 | 1,017,218,595.34 | 624,066,682.93 | 294,546,054.33 | 1,015,404,160 |
| 经营活动产生的现金流量净额 | 53,786,875.62 | 73,197,427.87 | 72,507,507.76 | 72,630,935.15 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 22,777,358.75 | 3,526,408.17 | 3,539,338.02 | 43,784,651.33 |
| 投资活动现金流出小计 | 254,288,088.52 | 171,068,784.23 | 74,596,330.45 | 300,432,995.21 |
| 投资活动产生的现金流量净额 | -231,510,729.77 | -167,542,376.06 | -71,056,992.43 | -256,648,343.88 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 541,031,477.99 | 421,231,477.99 | 351,531,477.99 | 417,800,000 |
| 筹资活动现金流出小计 | 296,383,078.79 | 224,191,495.6 | 42,196,173.66 | 253,979,501.69 |
| 筹资活动产生的现金流量净额 | 244,648,399.2 | 197,039,982.39 | 309,335,304.33 | 163,820,498.31 |
| 汇率变动对现金及现金等价物的影响 | -20,469,307.92 | -12,277,789.85 | -5,287,383.02 | 4,034,927.49 |
| 现金及现金等价物净增加额 | 46,455,237.13 | 90,417,244.35 | 305,498,436.64 | -16,161,982.93 |
| 期末现金及现金等价物余额 | 103,236,350.96 | 147,198,358.18 | 362,279,550.47 | 56,781,113.83 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 90,417,244.35 | - | -16,161,982.93 |